Rubius Therapeutics Raises $100 Million in Crossover Financing Post author:Sam Post published:February 28, 2018 Post category:BioPharma Rubius Therapeutics has closed on an oversubscribed $100 million crossover financing. Source: BioSpace You Might Also Like A Look at the 5 Most Profitable Biopharma Companies June 19, 2017 Simplify Medical, Inc. Announces First Patient Treated In U.S. Pivotal Trial Of MRI-Optimized Simplify Cervical Artifical Spinal Disc Used At Two Adjacent Levels April 11, 2017 Insulet, Mayo Clinic Jump in On $35 Million Series C Funding Round June 27, 2017
Simplify Medical, Inc. Announces First Patient Treated In U.S. Pivotal Trial Of MRI-Optimized Simplify Cervical Artifical Spinal Disc Used At Two Adjacent Levels April 11, 2017
